RBOT Vicarious Surgical
- 5.840
- +0.630+12.09%
- 5.840
- 0.0000.00%
Vicarious Surgical News
Morgan Stanley Maintains Vicarious Surgical(RBOT.US) With Hold Rating, Cuts Target Price to $6.5
Express News | Piper Sandler Maintains Neutral on Vicarious Surgical, Adjusts Price Target To $12 From $30 (1-for-30 Reverse Stock Split)
Vicarious Surgical Analyst Ratings
Vicarious Surgical | 10-Q: Q2 2024 Earnings Report
Earnings Call: Vicarious Surgical Q2 Results, Partnerships, and Outlook
TD Cowen Maintains Vicarious Surgical(RBOT.US) With Buy Rating, Maintains Target Price $10
Piper Sandler Maintains Vicarious Surgical(RBOT.US) With Hold Rating, Cuts Target Price to $12
Piper Sandler Sticks to Their Hold Rating for Vicarious Surgical (RBOT)
Express News | Vicarious Surgical Inc : TD Cowen Adjusts Target Price to $10 From $1.50 to Reflect 1-for-30 Reverse Stock Split
Vicarious Surgical's Progress and Upcoming Milestones Merit a Buy Rating
Earnings Call Summary | Vicarious Surgical(RBOT.US) Q2 2024 Earnings Conference
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript
Express News | Vicarious Surgical Reiterates Expected FY24 Cash Burn Of ~$50M
Express News | Vicarious Surgical Inc: Q2 Adj Shr Loss $2.86
Express News | Vicarious Surgical Inc - Reiterates Expected Full Year 2024 Cash Burn of Approximately $50 Mln
Express News | Vicarious Surgical Q2 2024 Adj. EPS $(2.86) Misses $(2.77) Estimate
Vicarious Surgical 2Q Loss/Shr $2.59 >RBOT
Express News | Vicarious Surgical Reports Second Quarter 2024 Financial Results
Vicarious Surgical (RBOT) Partners LSU Health New Orleans
Express News | Vicarious Surgical Announces New Hospital System Partnership With Lsu Health New Orleans
Analysis
Price Target
No Data
